Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer (Q28291526)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Lisa M Butler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jung-Mo Ahn

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Preethi Ravindranathan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Tae-Kyung Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Lin Yang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Wayne D Tilley

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Jer-Tsong Hsieh

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Ganesh V Raj

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

1 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

published in

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

1923

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

Steroid hormone receptors in prostate cancer: a hard habit to break?

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Androgen-response elements in hormone-refractory prostate cancer: implications for treatment development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Hormonal therapy for prostate cancer: toward further unraveling of androgen receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Mechanisms mediating androgen receptor reactivation after castration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Androgen receptor coactivators and prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Coactivator selective regulation of androgen receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

PELP1: A novel therapeutic target for hormonal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Significance of PELP1 in ER-negative breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Central role for PELP1 in nonandrogenic activation of the androgen receptor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Peptidomimetics and peptide backbone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Recognition and accommodation at the androgen receptor coactivator binding interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Solid-phase synthesis of tris-benzamides as α-helix mimetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Unraveling the complexities of androgen receptor signaling in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Oligobenzamide proteomimetic inhibitors of the p53-hDM2 protein-protein interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Controlling curvature in a family of oligoamide alpha-helix mimetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Design, synthesis, and evaluation of an alpha-helix mimetic library targeting protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Androgen receptor rediscovered: the new biology and targeting the androgen receptor therapeutically

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Management of metastatic castration-resistant prostate cancer: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

Novel amphiphilic alpha-helix mimetics based on a bis-benzamide scaffold

21 January 2018

1 reference

12 December 2020

Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer

1 reference

12 December 2020

Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance

1 reference

12 December 2020

Emerging significance of ER-coregulator PELP1/MNAR in cancer

1 reference

12 December 2020

Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR

1 reference

12 December 2020

Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2912

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NCOMMS2912

2 references

Consolidated OpenCitations Corpus – April 2017

1531162

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715282%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 March 2020

ADS bibcode

2013NatCo...4.1923R

0 references

1047915883

0 references

1531162

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

1531162